Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial by Gabay, Cem, MD, Emery, Paul, MD, van Vollenhoven, Ronald, MD, Dikranian, Ara, MD, Alten, Rieke, MD, Pavelka, Karel, MD, Klearman, Micki, MD, Musselman, David, MD, Agarwal, Sunil, MD, Green, Jennifer, MSc, Kavanaugh, Arthur, Dr

Get full text

The Comparison of Trial Data–Based and Registry Data–Based Cost-Effectiveness of Infliximab Treatment for Rheumatoid Arthritis in Sweden Using a Modeling Approach by Lekander, Ingrid, MSc, Kobelt, Gisela, PhD, MBA, Svarvar, Patrick, PhD, Ljung, Tryggve, MD, PhD, van Vollenhoven, Ronald, MD, PhD, Borgström, Fredrik, PhD

Get full text

Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-grou... by van Vollenhoven, Ronald F, Prof, Geborek, Pierre, MD, Forslind, Kristina, MD, Albertsson, Kristina, MD, Ernestam, Sofia, MD, Petersson, Ingemar F, MD, Chatzidionysiou, Katerina, MD, Bratt, Johan, MD

Get full text

Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised con... by Smolen, Josef S, Prof, Emery, Paul, Prof, Fleischmann, Roy, Prof, van Vollenhoven, Ronald F, Prof, Pavelka, Karel, Prof, Durez, Patrick, Prof, Guérette, Benoît, PhD, Kupper, Hartmut, MD, Redden, Laura, MD, Arora, Vipin, PhD, Kavanaugh, Arthur, Prof

Get full text

Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study by Smolen, Josef S, Prof, Burmester, Gerd-Rüdiger, Prof, Combe, Bernard, Prof, Curtis, Jeffrey R, Prof, Hall, Stephen, MD, Haraoui, Boulos, MD, van Vollenhoven, Ronald, Prof, Cioffi, Christopher, PhD, Ecoffet, Cécile, PharmD, Gervitz, Leon, PhD, Ionescu, Lucian, MD, Peterson, Luke, MS, Fleischmann, Roy, Prof

Get full text

Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international taskforce by Connelly, Kathryn, Eades, Laura E., Koelmeyer, Rachel, Ayton, Darshini, Golder, Vera, Kandane-Rathnayake, Rangi, Gregory, Kate, Brunner, Hermine, Burke, Laurie, Arnaud, Laurent, Askanase, Anca, Aranow, Cynthia, Vital, Ed, Pons-Estel, Guillermo, Dantata, Khadija, Andersen, Jeanette, Cornet, Alain, Buie, Joy, Sun, Ying, Tanaka, Yoshiya, Simon, Lee, Lahoud, Youmna, Friedman, Alan, Kalunian, Kenneth, Zuraw, Qing, Werth, Victoria, Garces, Sandra, Morand, Eric F.

Get full text

LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: Results from a randomized, double‐blind, placebo‐controlled study by Alarcón‐Segovia, Donato, Tumlin, James A., Furie, Richard A., McKay, James D., Cardiel, Mario H., Strand, Vibeke, Bagin, Robert G., Linnik, Matthew D., Hepburn, Bonnie

Get full text